Pushing treated solid material into a receptacle and sending effluent to the GENERATIONS filtration system. At every stage of the Veterinary process from Point of care, Animal Hospital/Clinic and the Animal Diagnostic Laboratory, vast quantities of Biohazardous waste are produced. This waste is usually comprised of Single use plastic, Sharps, Glass, or other forms of textiles. This novel validation system validates the efficacy of the GENERATIONS process during live waste processing ensuring the highest level of confidence in the efficacy.
Enva and Envetec Agree Strategic Collaboration
This process emits huge amounts of CO2 and other greenhouse gases, uses vast amounts of water and is incredibly damaging to the environment. According to Health Care Without Harm, the healthcare sector alone contributes 4.4% of global emissions, and that footprint is forecast to triple by 2050. Healthcare and life science organizations can now recycle biohazardous materials that were previously impossible to recycle.
Malcolm Bell
Following this he joined Technopath Distribution in 2005 as a Technical Sales representative and ultimately covered roles of increasing responsibility before becoming Business Development Manager. In 2015 Paul joined IDEXX Laboratories where he was Sales Manager for Europe and various Distribution territories. His experience includes Pharma, Med-Device, Food And Beverage as well as extensive knowledge of the Veterinary sector. Paul is passionate about creating clean change and is confident that we can have positive environmental impact by responsible treatment of Laboratory Biohazardous waste.
Furthermore, individual countries are implementing ambitious decarbonization plans that directly impact the veterinary science industry. In the United States, the Environmental Protection Agency (EPA) has established the AgStar program, which encourages the adoption of sustainable waste management practices in animal agriculture, including the recovery and utilization of biogas from animal waste. Furthermore, individual countries are implementing ambitious decarbonization plans that directly impact the Food & Beverage industry. In the European Union, the Farm to Fork Strategy (2020) calls for a transition to a sustainable food system, including the responsible management of waste streams and the reduction of environmental impacts along the entire supply chain. 90% of public pharma and companies analyzed in the sector still do not have emission reduction targets in the short-term (2021 – 2025) that are aligned with a 1.5°C increase world.
Previously, he was CFO of Technopath Clinical Diagnostics (until its sale to LGC Group in 2021), a provider of quality control solutions to clinical laboratories worldwide. Peter has served as a non-executive director of both public and private companies including Leon-Nanodrugs GmbH, Valitacell Limited, Merrion Pharmaceuticals plc, Cydex Pharmaceuticals Inc. and Antigenics Inc. Peter worked for the international public accounting firm of KPMG in Ireland and France and is a fellow of Chartered Accountants Ireland and a member of the Institute of Directors. Contact us to learn how GENERATIONS can help your veterinary facility transition to a sustainable biohazardous waste management solution, reducing environmental impact while unlocking economic opportunities through the circular economy and simultaneously eliminating the need to transport biohazardous waste from your facility. Globally, the management of biohazardous waste is subject to stringent regulations and guidelines set forth by organizations such as the World Organisation for Animal Health (OIE) and the Basel Convention. These frameworks aim to ensure the safe and responsible handling, treatment, and disposal of biohazardous materials, safeguarding both human and animal health while minimizing environmental impacts.
Keith is an Honorary Fellow Of the Royal College of Surgeons for his Role as Chair of the Healthy Ireland Council and holds an Honorary Doctor of Science from UL for services to Sport and Community. In addition, he is a Patron of both the Special Olympics and the UNESCO Chair for Inclusive Physical Education, Sport, Recreation, and Fitness in Tralee IT. Biohazardous waste in the veterinary context encompasses a wide range of materials, including infectious substances, sharps, pathological waste, and animal carcasses. The mishandling or improper disposal of these materials can lead to the spread of zoonotic diseases, environmental contamination, and the release of harmful pathogens into the ecosystem.
Redefining Healthcare PlasticsRead More
The pharmaceutical sector’s commitment to sustainability aligns with global initiatives aimed at reducing the carbon footprint of industrial operations. For instance, the European Union’s Pharmaceutical Strategy for Europe (2020) emphasizes the importance of minimizing the environmental impact of pharmaceutical manufacturing, including the responsible management of waste streams. Envetec’s mission is to revolutionise how laboratories across the life science sector treat biohazardous waste, particularly single-use plastics, significantly transforming how lab environments approach sustainability.
Ironically it is the very environment where animals inhabit that ultimately gets affected by climate change.Large veterinary care providers, small clinics and laboratories have committed to obtaining Net Zero status, many with ambitiously accelerated timelines. A key component of reaching Net Zero is to address the huge amount of waste that is produced by the Veterinary sector, particularly biohazardous waste (also referred to as Regulated Waste (RMW)). By eliminating high-carbon transportation and thermal treatments, GENERATIONS enables medical technology facilities to recycle waste that would otherwise end up in landfills. This innovative solution empowers the industry to significantly reduce its emissions and contribute to a more sustainable future. These actions are in line with the Health Service Executive (HSE) in Ireland, a public healthcare body, decarbonisation plans to become net zero energy related emissions by 2050 (HSE Infrastructure Decarbonisation Roadmap, 2021).
Reduce transport
By aligning the environmental interests of the planet, with the economic interest of the stakeholders, the sustainability effort can itself, become sustainable. GENERATIONS has been shown to reduce biohazardous waste treatment emissions by 90% on average (comprising scope 1,2 & 3) when compared to traditional treatment processes. Envetec’s culture is based on honesty, disruption, excellence, open communication and collaborative team work.GENERATIONS® is a game changing clean technology that makes a much needed practical step forward in the environmental space, helping make our world a little more sustainable. Former taoiseach Enda Kenny has been appointed as a non-executive director of Tipperary-based Envetec Sustainable Technologies Ltd, a start-up company focused on treating and eradicating biohazardous laboratory waste and material. Technologies like GENERATIONS that address the environmental challenges of single-use plastics, while aligning with economic interests, are crucial.
By doing so, Food and Beverage facilities can lower their emissions related to waste by up to 90%. Furthermore, individual countries are implementing ambitious decarbonization plans that directly impact the pharmaceutical industry. In the United Kingdom, the National Health Service (NHS) has set a goal of achieving net-zero emissions by 2040, with a particular focus on reducing single-use plastics and improving waste management practices. The NHS’s “Clinical Waste Strategy” specifically calls for the adoption of innovative technologies to enable on-site treatment of biohazardous waste, reducing the need for transportation and off-site incineration. Peter brings significant experience in corporate finance, business development and financial management in both public and private life science companies. Peter is a non-executive director of Avadel Pharmaceuticals plc, a NASDAQ listed biopharmaceutical company, and Oculer Limited, a company developing and commercialising proprietary rapid microbiology technology.
- These healthcare facilities produce significant amounts of biohazardous waste as a byproduct of providing care, diagnosis and medication.
- The Irish healthcare sector generates approximately 2.83 megatons of CO2 annually, while the NHS in the UK contributes around 4-5% of the nation’s total emissions.
- The high temperatures required for complete waste destruction contribute the majority of the environmental footprint of this process.
- The system’s unique capabilities lead to waste prevention by converting laboratory biohazardous waste into a recyclable polymer flake that is entirely safe to handle and transport for recycling.
- A key component of reaching Net Zero is to address the huge amount of waste that is produced by the healthcare sector, particularly biohazardous waste (also referred to as Regulated Medical Waste (RMW)).
Food & Beverage
Malcolm Bell serves as Chief Executive Officer of Envetec Sustainable Technologies, Ireland’s first cleantech company focused on breakthrough innovations to treat and repurpose biohazardous waste materials on-site, significantly reducing dependency on landfills, incineration and autoclaving. Addressing the growing urgency to achieve a substantive path toward net-zero from the diagnostic, healthcare, and food and beverage industries, Malcolm established Envetec as a standalone business in 2021. He served as CEO and oversaw the successful acquisition of the company to LGC in 2020.Malcolm has a track record of creating significant value by advancing assets, intellectual property, technology, and product portfolios.
Facilities can now send material to be recycled that otherwise would end up in landfill and/or incinerated. The transition to more sustainable biohazardous waste management practices not only aligns with environmental objectives but also presents economic opportunities for pharmaceutical companies. By embracing innovative technologies that enable the recovery and reuse of valuable materials from waste streams, companies can realize cost savings. For example, recovering high value polymers from what is typically considered waste can significantly reduce the need for purchasing virgin materials, improving resource efficiency. As the Food & Beverage industry continues to prioritize sustainability and responsible waste management, the adoption of disruptive technologies that effectively treat biohazardous waste while minimizing environmental impact will become increasingly essential. By aligning environmental stewardship with economic interests, the industry can foster a sustainable approach to biohazardous waste management that safeguards public health, protects the environment, and supports long-term business resilience.
Extended life expectancy as well as improving quality of life has been the direct result of improved therapeutics in almost all facets of life. Envetec GENERATIONS is an on-site, non-thermal, Clean Technology that treats biohazardous waste onsite in a quick, effective and sustainable way. Mr Kenny (71), who was taoiseach from 2011 to 2017, is one of five recent appointments to the board of the cleantech business, which has raised €10 million in new funding to support its growth. Mr Kenny has secured a number of directorships since stepping down as taoiseach, including with Heneghan, the Ireland China Institute and Carbon Collect Ltd.
- In the United States, the Environmental Protection Agency (EPA) has established the AgStar program, which encourages the adoption of sustainable waste management practices in animal agriculture, including the recovery and utilization of biogas from animal waste.
- For instance, the United Nations’ Sustainable Development Goals (SDGs) emphasize the importance of sustainable food production systems and responsible consumption and production patterns.
- As facilities are increasingly prioritising sustainability, the biomedical and healthcare industries are compelled to explore innovative technologies and methods that mitigate the environmental consequences of biohazardous waste treatment.
- His experience includes Pharma, Med-Device, Food And Beverage as well as extensive knowledge of the Veterinary sector.
This decarbonisation plan is in line with the Irish Government’s Climate Action Plan 2021 (Irish Government, 2021). Imogen spent her executive career in the fintech arena as Commercial Director of the London Stock Exchange and latterly President of two divisions of S&P Global. She brings global experience to the boards that she serves plus a strong commercial, client and talent-focused agenda while specialising in Remuneration Committee work on both listed and non-listed boards. While the mishandling or improper disposal of biohazardous waste can lead to the spread of foodborne illnesses and environmental contamination, the impact of traditional disposal methods on the environment is also extremely detrimental. GENERATIONS is helping the largest private hospital group in New York State treat their regulated medical waste sustainably and can also help your healthcare facility to achieve its pin up online casino sustainability goals. He established W2 over 25 years ago, creating a group of businesses that support marketing & strategic planning, leadership development, client acquisition.
Experienced Chair, Senior Independent Director and NED with global experience
The transition to more sustainable biohazardous waste management practices in the Food & Beverage industry not only aligns with environmental objectives but also presents economic opportunities. By doing so, Veterinary care facilities can lower their emissions related to waste by up to 90%. The veterinary science industry’s commitment to sustainability aligns with global initiatives aimed at reducing the carbon footprint of industrial operations and promoting a circular economy. For instance, the European Union’s Farm to Fork Strategy (2020) emphasizes the importance of sustainable food production systems, including responsible waste management practices along the entire supply chain.
National and International health systems have publicly acknowledged this threat and have taken responsibility by committing to reaching carbon net zero, in response to the profound and growing threat to health posed by climate change. A key component of reaching Net Zero is to address the huge amount of waste that is produced by the healthcare sector, particularly biohazardous waste (also referred to as Regulated Medical Waste (RMW)). The Food & Beverage industry’s commitment to sustainability aligns with global initiatives aimed at reducing the carbon footprint of industrial operations and promoting a circular economy. For instance, the United Nations’ Sustainable Development Goals (SDGs) emphasize the importance of sustainable food production systems and responsible consumption and production patterns. Paul gained his BSC from UCD and moved from University to roles covering both Laboratory and QA with the Kerry Group.